Submit Your Article CMED MEACR meeting
Home Print this page Email this page Users Online: 528
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login
Current Issue

November-December 2021 | Vol 10 | Issue 6

RSS Feed for Current Issue RSS Feed for Current Issue

Review Article
Diagnostic pitfalls in minimal deviation adenocarcinoma of the uterine cervix: Review and update
Cervical minimal deviation adenocarcinoma (MDA) is an extremely well-differentiated adenocarcinoma. This tumor often imposes diagnostic dilemma among pathologists as it is confused with a variety of...
[Abstract] | [HTML Full text] | [PDF] | [Mobile HTML Full text] | [EPub]
Original Article
Evaluation of novel MicroRNA profile-21 and 191 in oral leukoplakia and oral squamous cell carcinoma in comparison with healthy tissues – A cross-sectional study
Objective: The objective of this study was to identify whether microRNA (miR)-21 and miR-191 could be used as a potential biomarker in patients diagnosed with oral leukoplakia (OL) and oral s...
[Abstract] | [HTML Full text] | [PDF] | [Mobile HTML Full text] | [EPub]
Original Article
Role of fibrotic cancer stroma in rectal carcinoma: An immunomorphological assessment
Background: The aim of the study is to evaluate the role of fibrotic cancer stromal response and tumor budding in ectal adenocarcinoma development and progression. Materials and Methods:
[Abstract] | [HTML Full text] | [PDF] | [Mobile HTML Full text] | [EPub]
Original Article
Patterns of failure and arm disability following postmastectomy hypofractionated chest wall radiotherapy in resource-constrained tertiary care practice setting: A mono-institutional experience
Introduction: Radiotherapy for breast cancer has evolved over the years in terms of technique and dose fractionation. Hypofractionation for whole-breast radiotherapy has equivalent local cont...
[Abstract] | [HTML Full text] | [PDF] | [Mobile HTML Full text] | [EPub]
Original Article
Sarcopenia is a predictive marker for response to erlotinib in patients with lung adenocancer
Background: Adenocancer pathologic subtype, smoking history, and women gender have been known to predict the parameters such as the sensitivity to epidermal growth factor receptor tyrosine ki...
[Abstract] | [HTML Full text] | [PDF] | [Mobile HTML Full text] | [EPub]

Abstracting and Indexing Information

The journal is registered with the following abstracting partners:
Baidu Scholar, CNKI (China National Knowledge Infrastructure), EBSCO Publishing's Electronic Databases, Ex Libris Primo Central, Google Scholar, Hinari, Infotrieve, National Science Library, ProQuest, TDNet, Wanfang Data

The journal is indexed with, or included in, the following:
Emerging Sources Citation Index, Index Copernicus, Web of Science

  Clinical Cancer Investigation Journal

Clinical Cancer Investigation Journal, a publication of Middle-Eastern Association for Cancer Research (MEACR), is a peer-reviewed online journal with Quarterly print on demand compilation of issues published.

More about the journal >>

Submit your manuscripts

  • Online submission
  • Wider visibility though open access
  • Higher impact with wider visibility
  • Prompt review

Submit article online